Aster DM Healthcare Faces Financial Challenges Amidst Pledged Shares and Market Dynamics
Aster DM Healthcare has recently experienced a change in evaluation, reflecting its current position amid market dynamics. The company reported net sales of Rs 2,088.31 crore for Q2 FY24-25, with a Return on Capital Employed of 9.68% and a Debt to EBITDA ratio of 3.19 times, indicating financial challenges.
Aster DM Healthcare, a significant entity in the Hospital and Healthcare Services sector, has recently undergone an adjustment in evaluation. This revision reflects the company's current standing amidst various underlying trends and market dynamics.The financial metrics indicate that Aster DM Healthcare's net sales for the second quarter of FY24-25 were reported at Rs 2,088.31 crore, which represents a notable shift compared to previous periods. The company's Return on Capital Employed (ROCE) stands at 9.68%, suggesting challenges in generating returns relative to its capital base. Furthermore, the Debt to EBITDA ratio of 3.19 times raises questions about the company's capacity to manage its debt obligations effectively.
In terms of ownership structure, a significant portion of promoter shares, approximately 98.87%, is pledged, which could influence investor sentiment and market performance. Despite these factors, the stock's technical indicators are positioned within a mildly bullish range, suggesting some positive momentum in the short term.
Overall, while Aster DM Healthcare has shown resilience by outperforming the BSE 500 index over the past three years, the current financial landscape presents challenges that may impact its long-term prospects in the competitive healthcare sector.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
